Identifying the most critical behavioral lifestyles associated with MAFLD: evidence from the NHANES 2017-2020

• Published in: Frontiers in endocrinology (Lausanne) 2024-07, Vol.15, p.1375374
• Main Authors: Li, Sicheng, Chen, Jiajin, Zhang, Yuqin, Huang, Shourui, Pan, Qing, Tang, Dan, Lan, Tianjiao, Bu, Shichen, Wang, Yan
• Format: Article
• Language: English
• Subjects: Adult; Aged; Alcohol Drinking - epidemiology; BKMR; Cross-Sectional Studies; Endocrinology; Female; Humans; joint association; Life Style; lifestyle exposome; Male; Middle Aged; multiple exposure; Non-alcoholic Fatty Liver Disease - epidemiology; Nutrition Surveys; PAF; Risk Factors; Sleep - physiology; WQS
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2024.1375374

Accumulating studies have demonstrated associations between single lifestyle exposures and metabolic dysfunction-associated fatty liver disease (MAFLD). However, the joint effects of lifestyle exposures remain unclear, hindering the development of targeted prevention and control strategies. We aimed to investigate the joint associations between lifestyle exposomes and MAFLD. This study included 5,002 participants from NHANES 2017-2020. Lifestyle exposomes, including sleep duration, metabolic equivalent of task (MET), Healthy Eating Index (HEI)-2015 score, alcohol consumption, and smoke exposure, were identified from questionnaire data. MAFLD was diagnosed by vibration-controlled transient elastography measurements and laboratory data. A logistic regression model and the weighted quantile sum method were used to evaluate the associations of single and joint lifestyle exposomes, respectively, with MAFLD. The population attributable fractions (PAFs) were calculated to assess the population benefits of different intervention strategies. Per-quartile range increases in sleep duration (OR=0.883, 95% CI: 0.826-0.944), MET (0.916, 0.871-0.963), and HEI-2015 score (0.827, 0.756-0.904) were significantly associated with MAFLD. The joint exposure of sleep duration, MET, and HEI-2015 score was associated with MAFLD (0.772, 0.688-0.865), with the highest weight (importance) for MET (0.526). PAFs revealed greater intervention benefits for sleep and the HEI-2015 when the majority of the population (>5%) had a low MAFLD risk (weak intervention targets), whereas MET was the most efficient intervention strategy when minority populations (≤5%) had a low MAFLD risk (strong intervention targets). This study demonstrated significant associations between MAFLD and single and joint exposures to sleep duration, MET, and HEI-2015 and identified physical activity as the most important lifestyle factor. Further population benefit analyses may provide evidence and suggestions for population-level interventions.